أخبار البصيرة AI News Intelligence
الذكاء الاصطناعي إيجابي تحليل ذكي آلي Google DeepMind Blog 30 نيسان 2026, 05:14

DeepMind تطور مساعدًا سريريًا بالذكاء الاصطناعي

تستكشف Google DeepMind مسارًا جديدًا للرعاية الصحية المعززة بالذكاء الاصطناعي عبر تطوير نموذج «طبيب مساعد» يعمل إلى جانب الأطباء. يهدف التوجه إلى دعم اتخاذ القرار السريري وتحسين كفاءة الرعاية دون استبدال الدور البشري.

Enabling a new model for healthcare with AI co-clinician

لماذا يهم هذا الخبر؟

أهمية الخبر تكمن في انتقال الذكاء الاصطناعي الطبي من أدوات منفصلة إلى شريك سريري محتمل، ما قد يعيد تشكيل سير العمل داخل المستشفيات والعيادات.

سياق الخبر

Researching the path to AI-augmented care and development of an AI co-clinician.

فتح الخبر الأصلي
تغطية مرتبطة

المزيد من أخبار الذكاء الاصطناعي

Google’s Gemini 3.6 Flash targets enterprise agent token costs الذكاء الاصطناعي

Google’s Gemini 3.6 Flash targets enterprise agent token costs

Google has released Gemini 3.6 Flash and 3.5 Flash-Lite as new workhorses designed to cut latency and token costs for enterprise AI agents. The economics of running autonomous software agents inside a production environment come down to a fixed equation few vendors advertise directly. A model needs to reason through a multi-step task competently, but […] The post Google’s Gemini 3.6 Flash targets enterprise agent token costs appeared first on AI News .

AI 8/10
AI News
اقرأ المزيد ←
The AI Slot Machine Effect: Why Generative Feeds Disrupt Deep Work And How to Reclaim Focus الذكاء الاصطناعي

The AI Slot Machine Effect: Why Generative Feeds Disrupt Deep Work And How to Reclaim Focus

You open a generative AI tool expecting a quick boost. Ten minutes later, you’re still there, refining a prompt for the fourth time. The task you started with has drifted off to the side somewhere. Sound familiar? Knowledge workers in 2026 are running into this more and more. It makes sense once you look at […] The post The AI Slot Machine Effect: Why Generative Feeds Disrupt Deep Work And How to Reclaim Focus appeared first on AI News .

AI 0/10
AI News
اقرأ المزيد ←
Bristol Myers Squibb buys Nvidia AI system for drug discovery الذكاء الاصطناعي

Bristol Myers Squibb buys Nvidia AI system for drug discovery

Bristol Myers Squibb is purchasing an Nvidia DGX SuperPOD built on the chipmaker’s Vera Rubin architecture to support artificial intelligence use across its drug discovery and development operations. The pharmaceutical company said it will be the first life sciences group to acquire a DGX SuperPOD based on Vera Rubin. Nvidia introduced the architecture earlier this […] The post Bristol Myers Squibb buys Nvidia AI system for drug discovery appeared first on AI News .

AI 0/10
AI News
اقرأ المزيد ←